Replies to post #782210 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

well that means a lot coming from you (as a known NWBO critic). Agreed

Btw, it would not surprise me if many bears/antis made use of the MHRA’s consultation process to spam the agency with reasons why ECA should not become a guideline — which is also a reason why they now have to sift through it all.

[learningcurve2020]

There are likely many issues from the FDA’s opinion of all of it, to wondering why they never ran another trial, to ECA’s, to Patient level data, to selection criteria, to refreshed SOC figures, to extreme cost…

But meanwhile Cognate was sold and Advent is looking hot!

[AllSheWrote]

I think it's reasonable to assume the ECAs are one of the issues with MHRA.